BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Drachenberg CB, Papadimitriou JC, Chandra P, Haririan A, Mendley S, Weir MR, Rubin MF. Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies. Kidney Int Rep 2019;4:1555-67. [PMID: 31890997 DOI: 10.1016/j.ekir.2019.07.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Person F, Meyer SC, Hopfer H, Menter T. Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms. Virchows Arch 2021. [PMID: 34164707 DOI: 10.1007/s00428-021-03129-y] [Reference Citation Analysis]
2 Nankivell BJ, P’ng CH, Shingde M. Glomerular C4d Immunoperoxidase in Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.04.016] [Reference Citation Analysis]
3 Rosa-Guerrero P, Leiva-Cepas F, Agüera-Morales M, Navarro-Cabello MD, Rodríguez-Benot A, Torres-De-Rueda A. First Report in the Literature of Biopsy-Proven Noncollapsing Focal Segmental Glomerulosclerosis Relapse in a Second Renal Transplant Presenting With Thrombotic Microangiopathy: A Case Report. Transplant Proc 2021:S0041-1345(21)00627-8. [PMID: 34627595 DOI: 10.1016/j.transproceed.2021.07.056] [Reference Citation Analysis]
4 Zhu X, Tu L, Liu S, You H, Xue J, Hao C. Complete remission of nephrotic syndrome in a young woman with anti-LRP2 nephropathy after immunosuppressive therapy. BMC Nephrol 2020;21:364. [PMID: 32831033 DOI: 10.1186/s12882-020-02027-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Nankivell BJ, Shingde M, P’ng CH, Sharma A. The Clinical and Pathological Phenotype of Antibody-Mediated Vascular Rejection Diagnosed using Arterial C4d Immunoperoxidase. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.04.097] [Reference Citation Analysis]
6 Miquelestorena-Standley E, Jaulerry C, Machet MC, Rabot N, Barbet C, Hummel A, Karras A, Garrouste C, Crepin T, Ducloux D, Cousin M, Albert C, Rivalan J, Cornec-Le Gall E, Pourreau F, Deltombe C, Nochy D, Szlavik N, Felix S, Croué A, Buob D, Rioux-Leclerc N, Doucet L, Goujon JM, Renaudin K, Blanchard E, Eymieux S, Rabant M, Halimi JM. Clinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide study. Diagn Pathol 2020;15:62. [PMID: 32460869 DOI: 10.1186/s13000-020-00980-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Genest DS, Bonnefoy A, Khalili M, Merlen C, Genest G, Lapeyraque A, Patey N, Smail N, Royal V, Troyanov S. Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhao Y, Cai M, Jiang Z, Dong B, Yan Y, Wang Y, Zuo L. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study. Ren Fail 2022;44:428-33. [PMID: 35272568 DOI: 10.1080/0886022X.2022.2048016] [Reference Citation Analysis]
9 Medjeral-Thomas NR, Pickering MC, Cook HT. Complement and kidney disease, new insights. Curr Opin Nephrol Hypertens 2021;30:310-6. [PMID: 33767058 DOI: 10.1097/MNH.0000000000000705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kojima T, Inoue D, Wajima T, Uchida T, Yamada M, Ohsawa I, Oda T. Circulating immune-complexes and complement activation through the classical pathway in myeloperoxidase-ANCA-associated glomerulonephritis. Renal Failure 2022;44:714-23. [DOI: 10.1080/0886022x.2022.2068445] [Reference Citation Analysis]
11 Neves PDMM, Souza RA, Torres FM, Reis FA, Pinheiro RB, Dias CB, Yu L, Woronik V, Furukawa LS, Cavalcante LB, de Almeida Araújo S, Wanderley DC, Malheiros DM, Jorge LB. Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy. PLoS One 2020;15:e0233199. [PMID: 33147224 DOI: 10.1371/journal.pone.0233199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Zanoni F, Khairallah P, Kiryluk K, Batal I. Glomerular Diseases of the Kidney Allograft: Toward a Precision Medicine Approach. Seminars in Nephrology 2022;42:29-43. [DOI: 10.1016/j.semnephrol.2022.01.005] [Reference Citation Analysis]
13 Kanazawa N, Iyoda M, Hayashi J, Honda K, Oda T, Honda H. A case of acute poststreptococcal glomerulonephritis complicated by interstitial nephritis related to streptococcal pyrogenic exotoxin B. Pathol Int 2022. [PMID: 35147256 DOI: 10.1111/pin.13203] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Reinhard L, Stahl RAK, Hoxha E. Is primary membranous nephropathy a complement mediated disease? Mol Immunol 2020;128:195-204. [PMID: 33142137 DOI: 10.1016/j.molimm.2020.10.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Yaman B, Kumbaracı BS, Gómez González CA, Akalın T, Şen S. C4d as a Practical Marker for Cutaneous Amyloidosis. Am J Dermatopathol 2022;44:28-32. [PMID: 34889811 DOI: 10.1097/DAD.0000000000002057] [Reference Citation Analysis]
16 Eder M, Kozakowski N, Omic H, Aigner C, Kläger J, Perschl B, Reindl-Schwaighofer R, Bond G, Böhmig GA, Kikić Ž. Glomerular C4d in Post-Transplant IgA Nephropathy is associated with decreased allograft survival. J Nephrol 2021;34:839-49. [PMID: 33306182 DOI: 10.1007/s40620-020-00914-x] [Reference Citation Analysis]